Clene's presentation by CEO Rob Etherington and CFO Morgan Brown is ... Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and ...

SALT LAKE CITY - March 25, 2025 (NEWMEDIAWIRE) - Clene Inc. (NASDAQ ... that fosters productive conversations," said Rob Etherington, CEO and President of Clene. "JonesTrading is pleased to ...

SALT LAKE CITY - March 25, 2025 (NEWMEDIAWIRE) - Clene Inc. (NASDAQ ... that fosters productive conversations,” said Rob Etherington, CEO and President of Clene. “JonesTrading is pleased ...

Clene planning to submit a New Drug Application ... the resulting analyses in the third quarter," said Rob Etherington, President and CEO of Clene. "Our goal from these additional analyses ...

Clene plans to submit a New Drug Application ... the resulting analyses in the third quarter,” said Rob Etherington, President and CEO of Clene. “Our goal from these additional analyses ...

SALT LAKE CITY, March 24, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq ... analyses in the third quarter,” said Rob Etherington, President and CEO of Clene. “Our goal from these additional ...

SALT LAKE CITY, March 24, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq ... and then conduct the resulting analyses in the third quarter,” said Rob Etherington, President and CEO of Clene. "Our goal ...

President and CEO of Clene (CLNN). “Our goal from these additional analyses is to determine concordance of the NIH-sponsored EAP NfL data with NfL results in our HEALEY Platform Trial.